Indication

Chronic intestinal amebiasis

Chronic intestinal amebiasis is a persistent, non-fulminant parasitic infection of the large intestine caused by mucosal colonization and tissue invasion by the protozoan *Entamoeba histolytica*. Read more about Chronic intestinal amebiasis

5 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Chronic intestinal amebiasis therapies.

Showing 1–5 of 5 drugs

Filter & compare in the drug finder →Opens the drug finder with Chronic intestinal amebiasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic intestinal amebiasis.

Chronic intestinal amebiasis is a persistent, non-fulminant parasitic infection of the large intestine caused by mucosal colonization and tissue invasion by the protozoan *Entamoeba histolytica*.

It predominantly affects individuals in resource-limited regions with inadequate sanitation, as well as travelers, immigrants, or institutionalized populations exposed via the fecal-oral route.

Pathophysiologically characterized by ongoing colonic mucosal ulceration and inflammation, this chronic state typically manifests with recurrent or low-grade diarrhea—often alternating with constipation—alongside abdominal cramping, flatulence, fatigue, and weight loss that can clinically mimic inflammatory bowel disease.

If left untreated, chronic mucosal invasion can progress to localized inflammatory mass lesions, termed amebomas, or lead to extraintestinal complications.

Personalize your experience

Follow Chronic intestinal amebiasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it